Table 1

Characteristics of the individuals included in the survival analysis and degree of information validation

Birth yearNo. of individuals
(male:female ratio)
No. of living and deceased individuals on 1 January 2016
Median age (at death) (range)
Information about vHL status obtained from: registers (R) or family interviews (F)*
Patients with vHL
Born 1840–190011
(7:4)
11 deceased
Median age at death:
49 years (28–64 years)
0 living
R: 9
F: 2
Born 1901–195559
(26:33)
50 deceased
Median age at death:
43.5 years (12–88 years)
9 living
Median age: 66 years
(61–72 years)
R: 57
F: 2
Born 1956–201073
(36:37)
6 deceased
Median age at death:
46.5 years (34–53 years)
67 living
Median age: 35 years
(6–59 years)
R: 72
F: 1
Total143
(69:74)
67 deceased
Median age at death:
45 years (12–88 years)
76 living
Median age: 38.5 years
(6–72 years)
R: 138
F: 5
Non-vHL siblings
Born 1840–19002
(0:2)
2 deceased
Ages at death: 69 and 85 years
R: 2
F: 0
Born 1901–195576
(41:35)
46 deceased
Median age at death:
69 years (18–93 years)
30 living
Median age: 67 years (61–99 years)
R: 66
F: 10
Born 1956–201059
(32:27)
59 living
Median age: 44 years (7–60 years)
R: 36
F: 23
Total137
(73:64)
48 deceased
Median age at death:
68.5 years (18–93 years)
89 living
Median age: 54 years (7–99 years)
R: 104
F: 33
  • *R: Information confirmed in medical records/registers. This includes hospital records (including imaging and pathology reports), autopsy reports and data from the Danish Patient Register, the Death register/Death certificates, the Cancer Register and the national vHL research database. F: Information only from family interview.

  • vHL, von Hippel-Lindau disease.